About AMD Days
CDC OAMD and APHL have co-sponsored AMD day, AMD 2-day, Virtual AMD-days and now AMD days since 2016. This symposium began as an opportunity for OAMD-funded CDC projects to be shared and presented. It has evolved to be an opportunity for state and local public health laboratories, and CDC laboratories to present their work, network and hear from leaders in the field.
AMD Days 2024 was held on September 24–25, 2024 at the Courtyard by Marriott in Decatur, GA. The final program is available. Select session recordings are linked below.
A special thank you to APHL's corporate sponsors: Ceres Nanosciences, Clear Labs, Illumina, NEB, QIAGEN, Streck, Theiagen Genomics and Thermo Fisher Scientific.
We look forward to seeing you at AMD Days 2026.
Consent to Use Photographic Images
Registration and attendance at or participation in APHL conferences and other activities constitutes an agreement by the registrant to APHL’s use and distribution (both now and in the future) of the registrant’s or attendee’s image or voice, without compensation, in photographs, video and audio recordings and electronic reproductions of such events and activities. Attendance at this event similarly constitutes agreement by the participant to allow use of their image by the Centers for Disease Control and Prevention in agency-created promotional and other materials without compensation or further notification.
AMD Days 2024 Session Recordings
The final program is now available.
| Tuesday, September 24, 2024 |
| 9:00 am - 10:15 am | Plenary Session: Ten Years of AMD | John Barnes, PhD, deputy director, Office of Advanced Molecular Detection, Centers for Disease Control and Prevention Marie-Claire Rowlinson, PhD, D(ABMM), laboratory director, Florida Bureau of Public Health Laboratories Logan Fink, MS, bioinformatics lead scientist, Virginia Division of Consolidated Laboratory Services |
1:30 pm - 2:30 pm
| Round Robin Talks
| UnO!: How we're Deploying a Metagenomics Pipeline to Resolve Undetermined Outbreaks of foodborne Illness Andrew D. Huang, PhD, microbiologist/bioinformatician, Enteric Diseases Laboratory Branch, Centers for Disease Control and Prevention Characterizing Echinocandin Resistance in Candida auris by Analyzing FKS1 Mutations and Antifungal Susceptibility Testing (AST) Minimum Inhibitory Concentration (MIC) Breakpoints Thomas Iverson, MS, bioinformatics scientist, Utah Public Health Laboratory Expanding the Iterative Refinement Meta Assembler and DAIS-Ribosome framework: Integrating the Respiratory Syncytial Virus module Paritra Mandal, PhD, bioinformatician II, Coronavirus and Other Respiratory Viruses Laboratory Branch, Centers for Disease Control and Prevention Development and Validation of a Targeted Next-Generation Sequencing Clinical Assay for Detecting Antimicrobial Resistant Neisseria gonorrhoeae and Neisseria meningitidis Krithivasan Sankaranarayanan, PhD, research scientist, Wadsworth Center |
| 4:30 pm - 5:30 pm | Breakout Session: Long Read & Nanopore Sequencing
| Kelly Oakeson, PhD, next generation sequencing and bioinformatics chief scientist, Utah Public Health Laboratory |
| Wednesday, September 25, 2024 |
| 9:00 am - 9:30 am | IGNITE Talks
| Comparative Analysis of Core Genome MLST Callers Lee Katz, PhD, MS, bioinformatics engineer, Enteric Diseases Laboratory Branch, Centers for Disease Control and Prevention Shatavia Morrison, PhD, health scientist, Waterborne Disease Prevention Branch, Centers for Disease Control and Prevention A Combination of Long-Read and Short-Read Sequencing Reveals a Cluster of Myroides Clinical Cases in Alameda County Including Multiple Instances of a New Myroides Species David Hess, PhD, associate research professor, Nevada State Public Health Laboratory Multiple Approaches to Genomic Sequencing of Monkeypox Virus During the 2022-2023 Outbreak Crystal Gigante, PhD, microbiologist, Poxvirus and Rabies Branch, Centers for Disease Control and Prevention From Genes to Cell Types: Leveraging LLMs for Cell Type Annotation Yuanyuan Wang, PhD, associate service fellow, Advanced Diagnostics and Biotechnologies Branch, Centers for Disease Control and Prevention |
| 9:30 am - 10:30 am | Panel Discussion: Laboratory and Epidemiologist Communication Strategies
| Single Persisting Strain of Salmonella Hadar Linked to Ground Turkey and Backyard Poultry Suggests Ongoing Contamination Across Poultry Industries Lingzi Xiaoli, PhD, MS, associate service fellow, Outbreak Response and Prevention Branch, Centers for Disease Control and Prevention Real-time Utilization of Mpox Genomic Surveillance in a Public Health Investigation — King County, Washington, 2022-2023 Kathryn M. Lau, MPH, epidemiologist, Public Health – Seattle & King County Michaela Banks, MPH, BSN, RN, genomics program manager, Public Health – Seattle & King County Virginia Joint Genomics Program — Success Applying Genomic Results to a Neisseria meningitidis Statewide Outbreak Response, 2022-2024 Jenny Crain, MS, MPH, CPH, genomic epidemiologist, Virginia Department of Health |
| 1:15 pm – 2:15 pm | Debate: Wastewater Sequencing
| Shannon Matzinger, PhD, genomic surveillance program manager, Colorado Department of Public Health and Environment Marc Johnson, PhD, professor, Department of Molecular Biology and Immunology, University of Missouri |
| 2:45 pm – 3:45 pm | Workforce Development Efforts | Rituparna Mukhopadhyay, PhD, research scientist supervisor I, California Department of Public Health Jake Garfin, research scientist II – public health bioinformatician, Minnesota Department of Health Elizabeth Osborn, EdM, MPH, education director, Pathogen Genomics Center of Excellence (PGCoE) Education Lead, Harvard Medical School |
| 3:45 pm - 4:30 pm | Closing Session: Advanced Molecular Detection Platform Presentation & Closing Remarks | Advanced Molecular Detection Platform Presentation Elizabeth Neuhaus, PhD, lead health scientist, Office of Advanced Molecular Detection, Centers for Disease Control and Prevention David Jones, PhD, lead health scientist, Office of Advanced Molecular Detection, Centers for Disease Control and Prevention Closing Remarks Duncan MacCannell, PhD, director, Office of Advanced Molecular Detection, Centers for Disease Control and Prevention |
Questions